# Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

> **NCT01124630** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 21 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** CS-1008
- **DRUG:** FOLFIRI

## Key facts

- **NCT ID:** NCT01124630
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2013-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01124630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01124630, "Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01124630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*